
                      mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series by unknown
CASE REPORT Open Access
R248G cystic fibrosis transmembrane
conductance regulator mutation in three
siblings presenting with recurrent acute
pancreatitis and reproductive issues: a case
series
Seiichi Villalona1, Guillermo Glover-López2, Juan Antonio Ortega-García1*, Rosa Moya-Quiles2,
Pedro Mondejar-López3, Maria C. Martínez-Romero2, Mariano Rigabert-Montiel4, María D. Pastor-Vivero3
and Manuel Sánchez-Solís3
Abstract
Background: Mutational combinations of the cystic fibrosis transmembrane conductance regulator, CFTR, gene have
different phenotypic manifestations at the molecular level with varying clinical consequences for individuals
possessing such mutations. Reporting cystic fibrosis transmembrane conductance regulator mutations is important
in understanding the genotype-phenotype correlations and associated clinical presentations in patients with cystic
fibrosis. Understanding the effects of mutations is critical in developing appropriate treatments for individuals
affected with cystic fibrosis, non-classic cystic fibrosis, or cystic fibrosis transmembrane conductance regulator-
related disorders. This is the first report of related individuals possessing the R248G missense cystic fibrosis
transmembrane conductance regulator mutation and we present their associated clinical histories.
Case presentation: All three patients are of Spanish descent. Deoxyribonucleic acid analysis revealed that all three
siblings possessed a novel c.742A>G mutation, resulting in a p.Arg248Gly (R248G) amino acid change in exon 6 in trans
with the known N1303K mutant allele. Case 1 patient is a 39-year-old infertile man presenting with congenital
unilateral absence of the vas deferens and recurrent episodes of epigastric pain. Case 2 patient is a 32-year-old woman
presenting with periods of infertility, two previous spontaneous abortions, recurrent epigastric pain, and recurrent
pancreatitis. Case 3 patient is a 29-year-old woman presenting with recurrent pancreatitis and epigastric pain.
Conclusions: We report the genotype-phenotype correlations and clinical manifestations of a novel R248G cystic
fibrosis transmembrane conductance regulator mutation: congenital unilateral absence of the vas deferens in males,
reduced female fertility, and recurrent acute pancreatitis. In addition, we discuss the possible functional consequences
of the mutations at the molecular level.
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Background
Cystic fibrosis (CF), Online Mendelian Inheritance in Man
(OMIM) #219700, is a life-threatening autosomal reces-
sive monogenetic disease caused by mutations to the
cystic fibrosis transmembrane conductance regulator
(CFTR) gene (OMIM #602421). CFTR is an adenosine
triphosphate (ATP)-binding cassette (ABC) transporter
protein that functions as a chloride (Cl–) ion channel and
is expressed in the apical membrane of epithelial cells
lining the lungs, pancreas, gastrointestinal tract, and re-
productive system [1]. Transport of Cl– ions is important
in the movement of fluids required for the production of
free flowing mucus in these epithelia [1]. Mutations to the
CFTR gene phenotypically manifest themselves in variable
clinical outcomes including: progressive decrease in lung
function, recurrent colonization of opportunistic bacteria
such as Pseudomonas aeruginosa and Staphylococcus aur-
eus, pancreatic insufficiency (PI), and male infertility due
to congenital bilateral absence of the vas deferens
(CBAVD) or congenital unilateral absence of the vas def-
erens (CUAVD) [2, 3]. Accurate reporting of CFTR muta-
tions is of clinical interest in improving genetic screening
techniques, understanding CF genotype-phenotype corre-
lations, and treatments of individuals affected with CF,
non-classic CF, or CFTR-related disorders (CFTR-RD).
We present here the case of three related Spanish pa-
tients possessing a novel CFTR R248G missense mutation
in trans with the N1303K mutant allele. The hospital net-
work ethics committees and the institutional review boards
approved the study. Informed consent was obtained from
the patients. Molecular studies of genomic deoxyribonucleic
acid (DNA) were performed from extracted peripheral blood
samples of the patients. In the index case, the use of the
“Cystic Fibrosis Genotyping assay” (Abbott) kit identified a
c.3909C>G mutation responsible for a p.Asn1303Lys change.
After clinical evaluation was carried out, the sequencing of
exons and adjoining regions of the CFTR gene were con-
ducted by direct sequencing (3130X ABI PRISM sequencer;
Applied Biosystems, Foster City, CA, USA). The sequencing
analysis confirmed the previous mutation and identified a
c.742A>G mutation, resulting in a p.Arg248Gly amino acid
change in exon 6 of the CFTR gene. This new mutation was
passed paternally and is present in all three siblings.
Case presentation
Case 1 patient is a 39-year-old infertile man of Spanish
descent who was referred to our CF Unit for non-classic
CF evaluation after consulting with his primary care phys-
ician with regards to an inability to impregnate a woman
in 2 years. A clinical evaluation confirmed the diagnosis of
CUAVD on his left testicle and an in-depth past medical
history was obtained. His history revealed that he had pre-
viously undergone surgical repair for right testicular
hydrocele, recurrent episodes of acute pancreatitis with
heartburn, and epigastric pain associated with increasing
blood levels of amylase and lipase. Other potential causes
of acute pancreatitis were ruled out (gallstones, endocrine
problems and metabolic abnormalities, alcohol abuse, or
others drugs). Pulmonary function tests suggested that
case 1 patient does not have lung disease, although he has
tested positive for S. aureus colonization. His sweat test
averages of 47 mEq/l indicate borderline results for CF
diagnosis. A review of his past clinical history was unre-
markable for other CFTR-RDs. A non-classic CF clinical
evaluation and evaluation of the past medical histories of
his siblings were conducted as a means of examining
particular genetic associations.
Table 1 Clinical expression of three siblings with the N1303K/R248G cystic fibrosis transmembrane conductance regulator genotype
Patient 1 Patient 2 Patient 3
Current age 39-year-old man 32-year-old woman 29-year-old woman
Age of diagnosis 32 years 25 years 22 years
Chloride sweat test (mEq/L) 47 40 42
FEV1 % 82.2 86 84
FVC % 80.1 82 82.4
Respiratory disease No significant history No significant history 1 episode of bronchitis
1 episode of pneumonia
Bacterial colonization Staphylococcus aureus Staphylococcus aureus No significant history
Pancreatic and gastrointestinal
manifestations
• Recurrent epigastric pain associated with
pancreatitis
• 3 episodes of
pancreatitis
• 4 episodes of
pancreatitis
• Chronic heartburn • Recurrent epigastric
pain
Reproductive complications • CUAVD • 2 spontaneous
abortions
No significant history
• Testicular hydrocele • Periods of infertility
CUAVD congenital unilateral absence of the vas deferens, FEV1 forced expiratory volume in 1 second, FVC forced vital capacity
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Case 2 patient is a 32-year-old Spanish woman whose
past medical history was significant for periods of infer-
tility with two previous spontaneous abortions. Her his-
tory also included recurrent episodes of epigastric pain
and pancreatitis. The episodes of pancreatitis consisted
of periodic acute periumbilical abdominal pain, vomit-
ing, nausea, as well as a transient increase in enzymatic
levels of amylase and pancreatic lipase. Similar to case 1,
she had no prior medical or socio-behavioral histories
that could account for the recurrent episodes of epigas-
tric pain and pancreatitis. She exhibited normal lung
function and has tested positive for S. aureus
colonization. Her sweat test averages of 40 mEq/l indi-
cate borderline results for CF diagnosis.
Case 3 patient is a 29-year-old Spanish woman with a
past medical history of recurrent pancreatitis and epigas-
tric pain. Her presentations of recurrent epigastric pain
resembled that of the clinical history of case 1. Her epi-
sodes of recurrent pancreatitis were similar to the etiolo-
gies of case 2 with acute periumbilical abdominal pain,
vomiting, nausea, as well as a transient increase in the
enzymatic levels of amylase and pancreatic lipase. All
other medical and socio-behavioral histories were also
ruled out as potential causes of recurrent pancreatitis
and epigastric pain. Her clinical history indicated previ-
ous periods of pneumonia and bronchitis. She exhibited
normal lung function, has tested negative for S. aureus
colonization, and has no prior history of reproductive
problems. Her sweat test averages of 42 mEq/l indicate
borderline results for CF diagnosis. Table 1 shows the
summary of the clinical histories.
Discussion
The N1303K allele is a product of a missense mutation
in exon 21 of the CFTR gene [3], causing an asparagine
to lysine amino acid change in the nucleotide-binding
domain 2 (NBD2) of the CFTR protein (Cystic Fibrosis
Mutation Database, http://www.genet.sickkids.on.ca/
cftr). NBD2 is an ATPase domain of the CFTR protein
that is involved in closing of the ion channel via the
energy produced from ATP hydrolysis [4]. NBD2 muta-
tions can result in destabilization of channel activity and
significant reductions in channel permeability [4]. In
addition, N1303K is a class II trafficking mutation that
can cause folding or deficiency of protein maturation
and consequently result in absence or reduced quantity
of CFTR protein [1, 5]. This mutation has been hetero-
geneously associated with CBAVD and CUAVD in males
[6, 7] and moderate to severe PI [8]. Figure 1a illustrates
the two-dimensional model of the CFTR protein and
major functional regions.
The clinical phenotype of CUAVD in case 1 patient
is consistent with previous studies of the N1303K
mutation. Although correlations between CFTR
mutations and reproduction have been thoroughly in-
vestigated in male patients, studies also suggest that
CFTR mutations can result in reduced fertility in fe-
males due to the production of thick cervical mucus,
and increase the likelihood of spontaneous abortions
[9]. We propose that the N1303K mutation is respon-
sible for the periods of infertility in case 2 patient
and could also be related to her two spontaneous
abortions. The recurrent pancreatic problems ob-
served in all three patients may not be associated
with the N1303K mutation despite its classification as
a moderate to severe PI mutation [8]. Recurrent acute
pancreatitis is observed in significantly higher fre-
quencies among patients with CF carrying one or two
mild PI mutations than patients carrying only one
moderate to severe PI mutation [8].
All three patients in this case study possess a
novel R248G missense mutation in exon 6 of the
CFTR gene, causing an arginine to glycine amino
acid change. Arginine-248 is located in intracellular
loop 2/cellular loop 2 (ICL2/CL2) of the wild-type
CFTR protein (http://www.uniprot.org). Figure 1b il-
lustrates the wild-type primary protein structure
based on the properties of the amino acids. ICL2/
CL2 is both the largest and most hydrophilic loop of
the CFTR protein that stabilizes the full conductance
state of the channel [10]. Increased mean closed
times are associated with ICL2/CL2 mutations of the
CFTR protein [10].
In this study we conducted an extensive database and
literature review, where the R248G mutation is not re-
ported as an identified CFTR mutation. A similar mis-
sense mutation, R248T, has been previously reported as
a mild CFTR-RD mutation that is associated with
CBAVD and no other clinical phenotype (see Fig. 1c)
[11]. The R248G mutation may alter the normal ICL2/
CL2 function more than the R248T mutation based on
the clinical phenotypes of the three patients. An arginine
to threonine amino acid substitution alters residue
charge from positive to neutral but does not change po-
larity. An arginine to glycine substitution changes the
residue charge from positive to neutral as well as amino
acid polarity. In addition, an R258G missense mutation
located in the ICL2/CL2 domain was reported in a
French male with CBAVD [12]. Based on these previous
observations and three cases presented in this study, we
suggest that amino acid substitution of arginine residues
in the ICL2/CL2 domain of the CFTR protein with
amino acids of contrasting molecular properties in
charge and polarity could be associated with CBAVD
and/or CUAVD (see Fig. 1c). The missense mutation on
the ICL2/CL2 domain of the protein could result in in-
creased mean closed times of normal CFTR function
and contribute to increased thick epithelial viscosity of
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the reproductive tract of female patients. This could explain
the clinical histories of spontaneous abortions and periods
of infertility in case 2 patient. We also postulate that this
mutation may have had an impact on the normal develop-
ment of the male reproductive organs in case 1 patient that
resulted in CUAVD. We have incorporated Additional files
1 and 2 to show the chromatogram and the amino acid se-
quence confirming the presence of the c.742A>G.
Conclusions
We suggest that the R248G mutation may be associated
with the recurrent acute pancreatitis exhibited by case 2
and case 3 patients because it is unlikely that the
N1303K moderate to severe PI mutation is the under-
lying molecular cause when taking into consideration
that each patient has only one copy of this mutant allele
[8]. The recurrent episodes of epigastric pain and heart-
burn observed in case 1 and case 2 patients could be
symptomatically masking the clinical signs of recurrent
acute pancreatitis [13, 14].
In this case series we report the potential genotype-
phenotype correlations with the novel R248G CFTR muta-
tion: CUAVD in males, reduced female fertility, and recur-
rent acute pancreatitis. Future structure-functional studies
on the CFTR protein can provide further insight on the
impact of the R248G mutation at the molecular level.
Additional files
Additional file 1: Direct sequencing of exon 6 of cystic fibrosis
transmembrane conductance regulator gene by the standard Sanger
method confirming the presence of the c.742A>G change in all three
patients. A.) Representative chromatogram for the wild-type forward strand
5′→ 3′ sequence. B.) Representative chromatogram of the mutated forward
strand 5′→ 3′ sequence. (DOCX 106 kb)
Additional file 2: Human cystic fibrosis transmembrane conductance
regulator nucleotide and amino acid sequence. Unique nucleotide sequence
GATGATGAAGTACA is present in wild-type cystic fibrosis transmembrane
Fig. 1 Cystic fibrosis transmembrane conductance regulator protein. a Two-dimensional model of the cystic fibrosis transmembrane conductance
regulator protein with major functional components. b Wild-type intracellular loop 2/cellular loop 2 primary protein structure depicting amino acid
properties. c Intracellular loop 2/cellular loop 2 regions clinically associated with congenital bilateral absence of the vas deferens or congenital unilateral
absence of the vas deferens resulting from a reported missense mutation. ICL2/CL2 intracellular loop 2/cellular loop 2, NBD1 nucleotide-binding domain
1, NBD2 nucleotide-binding domain 2
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conductance regulator protein. GATGATGAAGTAACG sequence observed in
all three patient cases is due to a c.742A>G mutation, resulting in codon
change from AGA to GGA and consequent arginine to glycine change. (RTF
600 kb)
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